Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA.
Magnetospirillum
Modulation of DNA transcription: The future of ASO therapeutics?
Munsey, Douglas
Sutaria, Shiv
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Modulation of DNA transcription: The future of ASO therapeutics?
Khvorova A. Modulation of DNA transcription: The future of ASO therapeutics? Cell. 2022 06 09; 185(12):2011-2013.
View in:
PubMed
subject areas
DNA
Exons
Histone Deacetylase Inhibitors
Humans
Muscular Atrophy, Spinal
Oligonucleotides, Antisense
authors with profiles
Anastasia Khvorova PhD